A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to message these profiles directly for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Voice Worries
However, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could result in users injecting substances of unknown origin.
Several professionals said the popularity for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.
Service Response and Material Elimination
Based on TikTok, the service has removed violative content and banned related keywords and query recommendations. The company stated it was committed to maintaining the service safe and investing in enhancing enforcement strategies.
Digital Trading Activities
Research also discovered groups with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, populated with images of weight loss, glowing reviews and detailed guides for mixing or administering at residence.
After moments of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.
Product Information and Pricing
Inside these groups, messages display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has previously encountered patients harmed by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious medical dangers”.
